Treatment of dairy cows at parturition with prostaglandin F2α or oxytocin for prevention of retained fetal membranes

Journal of the American Veterinary Medical Association

Volumn 211, Issue 10, 1997, Pages 1280-1284

  Stevens, Reyneld D ^a   Dinsmore, R Page ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FENPROSTALENE; OXYTOCIN; PROSTAGLANDIN F2 ALPHA; PROSTAGLANDIN F2 ALPHA TROMETAMOL;

ANIMAL EXPERIMENT; ARTICLE; CHILDBIRTH; COW; DRUG EFFECT; DRUG EFFICACY; FEMALE; INTRAMUSCULAR DRUG ADMINISTRATION; NONHUMAN; RETAINED PLACENTA; SUBCUTANEOUS DRUG ADMINISTRATION; UTERUS CONTRACTILITY;

ABORTIFACIENT AGENTS, NONSTEROIDAL; ANIMALS; BREEDING; CATTLE; CATTLE DISEASES; DINOPROST; FEMALE; INCIDENCE; LABOR, OBSTETRIC; OXYTOCICS; OXYTOCIN; PLACENTA, RETAINED; PREGNANCY; PROSPECTIVE STUDIES; PROSTAGLANDINS F, SYNTHETIC; REGRESSION ANALYSIS; REPRODUCTION; TIME FACTORS;

EID: 0030719540     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Kaneene JB, Hurd HS. National animal health monitoring system in Michigan. III. Cost estimates of selected dairy cattle diseases. Prev Vet Med 1990;8:127-140.
2. VanCamp SD. Hormone use in postpartum dairy cows. Vet Med 1991;86:640-653.
3. Olson JD, Bretzlaff KN, Mortimer RG, et al. The metritispyometra complex. In: Morrow DA, ed. Current therapy in theriogenology. 2nd ed. Philadelphia: WB Saunders Co, 1986;227-236.
4. Arthur GH. Retention of the afterbirth in cattle: a review and commentary. Vet Annu 1979;19:26-36.
5. van Werven T, Shukken YH, Lloyd J, et al. The effects of duration of retained placenta on reproduction, milk production, postpartum disease and culling rate. Theriogenology 1992;37:1191-1203.
6. Erb RE, Hinze PM, Gildow EM, et al. Retained fetal membranes - the effect on prolificacy of dairy cattle. J Am Vet Med Assoc 1958;133:489-496.
7. Sandals WCD, Curtis RA, Cote JF, et al. The effect of retained placenta and metritis complex on reproductive performance in dairy cattle - a case control study. Can Vet J 1979;20:131-135.
8. Erb HN, Smith RD, Oltenacu PA, et al. Path model of reproductive disorders and performance, milk fever, mastitis, milk yield, and culling in Holstein cows. J Dairy Sci 1985;68:3337-3349.
9. Halpern NE, Erb HN, Smith RD. Duration of retained fetal membranes and subsequent fertility in dairy cows. Theriogenology 1985;23:807-813.
10. Pelissier CL. Dairy cattle breeding problems and their consequences. Theriogenology 1976;6:575-583.
11. Dyrendahl I, Mattson J, Pehrson B. Retained placenta in cattle - incidence, clinical data and effects on fertility. Zentralbl Veterinarmed [A] 1977;24:529-541.
12. Joosten I, Stelwagen J, Dijkhuizen AA. Economic and reproductive consequences of retained placenta in dairy cattle. Vet Rec 1988;123:53-57.
13. Oltenacu PA, Frick A, Lindhe B. Epidemiological study of several clinical diseases, reproductive performance and culling in primiparous Swedish cattle. Prev Vet Med 1990;9:59-74.
14. Stevenson JS, Call EP. Reproductive disorders in the periparturient dairy cow. J Dairy Sci 1988;71:2572-2583.
15. Fairclough RJ, Hunter JT, Welch RAS. Peripheral plasma progesterone and utero-ovarian prostaglandin F concentrations in the cow around parturition. Prostaglandins 1975;9:901-914.
16. Guilbault LA, Thatcher WW, Drost M, et al. Source of F series prostaglandins during the early postpartum period in cattle. Biol Reprod 1984;31:879-887.
17. Peter AT, Bosu WTK. Peripartal endocrine changes associated with retained placenta in dairy cows. Theriogenology 1987;28:383-394.
18. 2 alpha and prostacyclin imbalance in cows with placental retention: new findings. Ann Rech Vet 1986;17:395-399.
19. 2α and nutritional parameters at parturition in dairy cows with and without retained placenta: relation to prepartum diet. Theriogenology 1992;38:407-418.
20. Heuwieser W, Grunert E, Hoppen H-O. A dystocia and caesarean section model to characterize uteroplacental prostaglandin concentrations associated with retained placenta in dairy cattle. Theriogenology 1993;40:159-166.
21. 2α concentration in maternal and foetal cotyledons of cows with and without retained fetal membranes. Zentralbl Veterinarmed [A] 1980;27:691-696.
22. Gross TS, Williams WF, Manspeaker JE, et al. Bovine placental prostaglandin synthesis in vitro as it relates to placental separation. Prostaglandins 1987;34:903-917.
23. Slama H, Vaillancourt D, Goff AK. Control of in vitro prostaglandin F2α and E2 synthesis by caruncular and allantochorionic tissues from cows that calved normally and those with retained fetal membranes. Domest Anim Endocrinol 1994;11:175-185.
24. 2α administration: clinical implication. Am J Vet Res 1981;42:314-317.
25. 2α, E2 and cloprostenol. Theriogenology 1987;27:349-358.
26. Ko JCH, McKenna DJ, Whitmore HL, et al. Effects of estradiol cypionate and natural and synthetic prostaglandins on myometrial activity in early postpartum cows. Theriogenology 1989;32:537-543.
27. 2α and oxytocin on the postpartum cow. Am J Vet Res 1984;45:1011-1014.
28. Jackson PS, Jessup R. Secondary pharmacological properties of prostaglandins. Vet Rec 1984;114:168.
29. 2α analog) in vivo and in vitro in the bovine. Theriogenology 1989;32:755-765.
30. 2α, and oxytocin in the ovariectomized ewe. Am J Vet Res 1985;46:841-844.
31. Burton MJ, Herschler RC, Dziuk HE, et al. Effect of fenprostalene on postpartum myometrial activity in dairy cows with normal or delayed placental expulsion. Br Vet J 1987;143:549-554.
32. Gross TS, Williams WF, Moreland TW. Prevention of the retained fetal membrane syndrone (retained placenta) during induced calving in dairy cattle. Theriogenology 1986;26:365-375.
33. 2α on placental expulsion in dairy cattle after caesarean section. Vet Rec 1993;132:507-508.
34. Garcia A, Barth AD, Mapletoft RJ. The effects of treatment with cloprostenol or dinoprost within one hour of induced parturition on the incidence of retained placenta in cattle. Can Vet J 1992;33:175-183.
35. Gross TS. Retained fetal membranes in cattle: subsequent reproductive preformance and prostaglandin therapy, in Proceedings. Annu Meet Soc Theriogenology 1988;226-233.
36. Herschler RC, Lawrence JR. A prostaglandin analogue for therapy of retained placenta. Vet Med 1984;79:822-826.
37. Studer E, Holtan A. Treatment of retained placentas in dairy cattle with prostaglandin. Bovine Pract 1986;21:159-160.
38. Callahan CJ, Horstman LA, Frank DJ. A comparison of fenprostalene and oxytetracycline as treatment for retained fetal membranes in dairy cows. Bovine Pract 1988;23:21-23.
39. Stevens RD, Dinsmore RP, Cattell MB. Evaluation of the use of intrauterine infusions of oxytetracycline, subcutaneous injections of fenprostalene, or a combination of both, for the treatment of retained fetal membranes in dairy cows. J Am Vet Med Assoc 1995;207:1612-1615.
40. Curtis RA. Prevention of retained fetal membranes in cattle. Vet Rec 1973;92:292-293.
41. Studer E, Hirose K, Hotman A, et al. Efficacy of oxytocin versus fenprostalene for the prevention of retained placenta in the dairy cow. Bovine Pract 1989;24:81-82.
42. Hosmer DW, Lemeshow S. Applied logistic regression. New York: John Wiley & Sons, 1989;25-37.